Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy? | Microbiome Res Rep | 2023 | 38045924 | PubTator, text mining | PubMed |
| Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy. | Front Pharmacol | 2023 | 38044951 | PubTator, text mining | PubMed |
| Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab. | Clin Ophthalmol | 2023 | 38026602 | PubTator, text mining | PubMed |
| Peptide RL-QN15 promotes wound healing of diabetic foot ulcers through p38 mitogen-activated protein kinase and smad3/miR-4482-3p/vascular endothelial growth factor B axis. | Burns Trauma | 2023 | 38026443 | PubTator, text mining | PubMed |
| Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options. | J Contemp Brachytherapy | 2023 | 38026080 | PubTator, text mining | PubMed |
| AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. | J Hepatocell Carcinoma | 2023 | 38022728 | PubTator, text mining | PubMed |
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study. | Front Immunol | 2023 | 38022513 | PubTator, text mining | PubMed |
| Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke-PROSCIS-B. | J Am Heart Assoc | 2023 | 38014691 | PubTator, text mining | PubMed |
| Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment. | Molecules | 2023 | 38005235 | PubTator, text mining | PubMed |
| The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin. | Life (Basel) | 2023 | 38004288 | PubTator, text mining | PubMed |
| Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma. | J Pers Med | 2023 | 38003931 | PubTator, text mining | PubMed |
| Carnosine, Zinc and Copper: A Menage a Trois in Bone and Cartilage Protection. | Int J Mol Sci | 2023 | 38003398 | PubTator, text mining | PubMed |
| Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation. | Biomolecules | 2023 | 38002312 | PubTator, text mining | PubMed |
| Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy-A Review. | Biomedicines | 2023 | 38001952 | PubTator, text mining | PubMed |
| Whole Genome Expression Profiling of Semitendinosus Tendons from Children with Diplegic and Tetraplegic Cerebral Palsy. | Biomedicines | 2023 | 38001919 | PubTator, text mining | PubMed |
| Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. | Curr Oncol | 2023 | 37999111 | PubTator, text mining | PubMed |
| Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis. | BMC Ophthalmol | 2023 | 37990182 | PubTator, text mining | PubMed |
| Endothelial progenitor cells in pregnancy-related diseases. | Clin Sci (Lond) | 2023 | 37986615 | PubTator, text mining | PubMed |
| A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer. | Discov Oncol | 2023 | 37981593 | PubTator, text mining | PubMed |
| Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. | Gut Microbes | 2023 | 37979154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=12